TY - JOUR
T1 - Genetic risk for coronary artery disease in individuals with or without type 2 diabetes
AU - Yamada, Yoshiji
AU - Ichihara, Sahoko
AU - Izawa, Hideo
AU - Tanaka, Masashi
AU - Yokota, Mitsuhiro
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.Y.), a grant from Mitsui Life Social Welfare Foundation (to M.Y.), and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y.Y.).
PY - 2004/4
Y1 - 2004/4
N2 - Given that a substantial proportion of individuals with coronary artery disease (CAD) also have type 2 diabetes, it is important to identify genes that confer susceptibility to CAD independently in subjects with type 2 diabetes and in those without this condition. A large-scale association study was performed to identify genes that confer susceptibility to CAD in either the absence or presence of type 2 diabetes. The study population comprised 5207 unrelated Japanese individuals, including 3085 subjects with CAD and 2122 controls. Among all subjects, 1704 individuals had type 2 diabetes and 3503 individuals did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, hypercholesterolemia, and hyperuricemia revealed that the following polymorphisms were significantly (P<0.005) associated with CAD: the 1019C→T of the connexin 37 gene for men with type 2 diabetes; the 2445G→A in the fatty acid-binding protein 2 gene for women with this condition; the -863C→A in the tumor necrosis factor-α gene, the -219G→T in the apolipoprotein E gene, the 1019C→T in the connexin 37 gene for men without type 2 diabetes; and the -482C→T in the apolipoprotein C-III gene for women without this condition. Genotyping of these polymorphisms may prove informative for assessment of the genetic risk for CAD in the absence or presence of type 2 diabetes.
AB - Given that a substantial proportion of individuals with coronary artery disease (CAD) also have type 2 diabetes, it is important to identify genes that confer susceptibility to CAD independently in subjects with type 2 diabetes and in those without this condition. A large-scale association study was performed to identify genes that confer susceptibility to CAD in either the absence or presence of type 2 diabetes. The study population comprised 5207 unrelated Japanese individuals, including 3085 subjects with CAD and 2122 controls. Among all subjects, 1704 individuals had type 2 diabetes and 3503 individuals did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, hypercholesterolemia, and hyperuricemia revealed that the following polymorphisms were significantly (P<0.005) associated with CAD: the 1019C→T of the connexin 37 gene for men with type 2 diabetes; the 2445G→A in the fatty acid-binding protein 2 gene for women with this condition; the -863C→A in the tumor necrosis factor-α gene, the -219G→T in the apolipoprotein E gene, the 1019C→T in the connexin 37 gene for men without type 2 diabetes; and the -482C→T in the apolipoprotein C-III gene for women without this condition. Genotyping of these polymorphisms may prove informative for assessment of the genetic risk for CAD in the absence or presence of type 2 diabetes.
UR - http://www.scopus.com/inward/record.url?scp=1842575741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842575741&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2004.01.014
DO - 10.1016/j.ymgme.2004.01.014
M3 - Article
C2 - 15059615
AN - SCOPUS:1842575741
SN - 1096-7192
VL - 81
SP - 282
EP - 290
JO - Molecular Genetics and Metabolism
JF - Molecular Genetics and Metabolism
IS - 4
ER -